MedinCell Revenue

In the fiscal year ending March 31, 2026, MedinCell had annual revenue of 19.52M EUR, down -23.21%. MedinCell had revenue of 7.91M in the half year ending March 31, 2026, with 286.42% growth.

Revenue

19.52M

Revenue Growth

-23.21%

P/S Ratio

38.36

Revenue / Employee

173.41K

Employees

140

Market Cap

931.35M

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	19.52M	-5.90M	-23.21%
Mar 31, 2025	25.42M	16.39M	181.43%
Mar 31, 2024	9.03M	-857.00K	-8.67%
Mar 31, 2023	9.89M	1.55M	18.60%
Mar 31, 2022	8.34M	152.00K	1.86%
Mar 31, 2021	8.19M	5.33M	187.03%
Mar 31, 2020	2.85M	1.41M	97.78%
Mar 31, 2019	1.44M	-5.00M	-77.61%
Mar 31, 2018	6.44M	-2.09M	-24.54%
Mar 31, 2017	8.53M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Valneva SE	156.33M
Genfit	70.85M
Cellectis	65.14M
Nanobiotix	32.59M
Innate Pharma	9.01M
Transgene	7.21M
Inventiva	6.76M
Sensorion	5.81M

Revenue Rankings

MedinCell News

4 days ago - Medincell: UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook - Business Wire
6 days ago - Medincell Continues to Strengthen and Renew its Board of Directors with the Proposed Appointment of Dr. Elisabeth Svanberg - Business Wire
18 days ago - Medincell Aligns Debt Maturity with Its Expected Revenue Growth Trajectory - Business Wire
6 weeks ago - MedinCell Slides: Corporate presentation - Filings
6 weeks ago - MedinCell Transcript: H2 25/26 - Transcripts
6 weeks ago - MedinCell Earnings release: H2 2026 - Filings
6 weeks ago - MedinCell Slides: H2 2026 - Filings
6 weeks ago - Medincell Reports FY 2025-26 Annual Results - Business Wire

More News